So instead of just helping patients eat less, this therapy may also help them burn more calories, essentially targeting both sides of the energy balance equation, says Bonarrigo
Place the mixture in a sealed container, like a plastic bag
One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and - and -cell function and reduces endogenous glucose release in patients with type 2 diabetes
[22] Read more in our feature on Lactobacillus gasseri
Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells
These drugs are extremely effective for blood glucose control and weight management, which, combined with their relatively limited side effect profile, makes them very appealing for diabetes treatment the purpose for which they originally received FDA approval